| David Shawn Malone, MD | |
|
217 W Cataldo, Spokane, WA 99201-2217 | |
| (509) 624-2326 | |
| (509) 744-3040 |
| Full Name | David Shawn Malone |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 32 Years |
| Location | 217 W Cataldo, Spokane, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881644086 | NPI | - | NPPES |
| 1021259 | Medicaid | WA | |
| 0173490 | Other | WA | LABOR & INDUSTRIES |
| P0008234 | Other | WA | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | MD00036576 (Washington) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Providence Health And Services Washington | 0345139929 | 687 |
News Archive
Onyx Pharmaceuticals, Inc. has announced that it has acquired an option to license rights to SB1518, an orally available, potent, and selective inhibitor of Janus Kinase 2 (JAK2), and SB1578, also a JAK2 inhibitor, from S*BIO Pte Ltd based in Singapore.
To reverse the opioid crisis that continues to grip the nation, the National Institutes of Health has awarded $945 million in total fiscal year 2019 funding for grants, contracts and cooperative agreements across 41 states through the Helping to End Addiction Long-term Initiative or NIH HEAL Initiative.
Consuming two or more drinks per day could increase a person's risk of pancreatic cancer by about 22 percent, according to data published in Cancer Epidemiology, Biomarkers and Prevention , a journal of the American Association for Cancer Research.
Rheumatoid arthritis (RA) patients are partially protected by the influenza vaccine 6-10 months after treatment with rituximab. Researchers determined that while the flu vaccine is safe, it is ineffective for RA patients in the first 6 months following rituximab treatment.
› Verified 8 days ago
| Entity Name | Columbia Surgical Specialists, Ps |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417067372 PECOS PAC ID: 2860305505 Enrollment ID: O20031110000300 |
News Archive
Onyx Pharmaceuticals, Inc. has announced that it has acquired an option to license rights to SB1518, an orally available, potent, and selective inhibitor of Janus Kinase 2 (JAK2), and SB1578, also a JAK2 inhibitor, from S*BIO Pte Ltd based in Singapore.
To reverse the opioid crisis that continues to grip the nation, the National Institutes of Health has awarded $945 million in total fiscal year 2019 funding for grants, contracts and cooperative agreements across 41 states through the Helping to End Addiction Long-term Initiative or NIH HEAL Initiative.
Consuming two or more drinks per day could increase a person's risk of pancreatic cancer by about 22 percent, according to data published in Cancer Epidemiology, Biomarkers and Prevention , a journal of the American Association for Cancer Research.
Rheumatoid arthritis (RA) patients are partially protected by the influenza vaccine 6-10 months after treatment with rituximab. Researchers determined that while the flu vaccine is safe, it is ineffective for RA patients in the first 6 months following rituximab treatment.
› Verified 8 days ago
| Entity Name | Providence Health & Services Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194099390 PECOS PAC ID: 0345139929 Enrollment ID: O20040311001453 |
News Archive
Onyx Pharmaceuticals, Inc. has announced that it has acquired an option to license rights to SB1518, an orally available, potent, and selective inhibitor of Janus Kinase 2 (JAK2), and SB1578, also a JAK2 inhibitor, from S*BIO Pte Ltd based in Singapore.
To reverse the opioid crisis that continues to grip the nation, the National Institutes of Health has awarded $945 million in total fiscal year 2019 funding for grants, contracts and cooperative agreements across 41 states through the Helping to End Addiction Long-term Initiative or NIH HEAL Initiative.
Consuming two or more drinks per day could increase a person's risk of pancreatic cancer by about 22 percent, according to data published in Cancer Epidemiology, Biomarkers and Prevention , a journal of the American Association for Cancer Research.
Rheumatoid arthritis (RA) patients are partially protected by the influenza vaccine 6-10 months after treatment with rituximab. Researchers determined that while the flu vaccine is safe, it is ineffective for RA patients in the first 6 months following rituximab treatment.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David Shawn Malone, MD Po Box 421, Liberty Lake, WA 99019-0421 Ph: (866) 747-2455 | David Shawn Malone, MD 217 W Cataldo, Spokane, WA 99201-2217 Ph: (509) 624-2326 |
News Archive
Onyx Pharmaceuticals, Inc. has announced that it has acquired an option to license rights to SB1518, an orally available, potent, and selective inhibitor of Janus Kinase 2 (JAK2), and SB1578, also a JAK2 inhibitor, from S*BIO Pte Ltd based in Singapore.
To reverse the opioid crisis that continues to grip the nation, the National Institutes of Health has awarded $945 million in total fiscal year 2019 funding for grants, contracts and cooperative agreements across 41 states through the Helping to End Addiction Long-term Initiative or NIH HEAL Initiative.
Consuming two or more drinks per day could increase a person's risk of pancreatic cancer by about 22 percent, according to data published in Cancer Epidemiology, Biomarkers and Prevention , a journal of the American Association for Cancer Research.
Rheumatoid arthritis (RA) patients are partially protected by the influenza vaccine 6-10 months after treatment with rituximab. Researchers determined that while the flu vaccine is safe, it is ineffective for RA patients in the first 6 months following rituximab treatment.
› Verified 8 days ago
Shane A Zim, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 217 W Cataldo Ave, Spokane, WA 99201 Phone: 509-624-2326 Fax: 509-252-2837 | |
Michael Joseph Cruz, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 217 W Cataldo Ave Fl 2, Spokane, WA 99201 Phone: 509-624-2326 Fax: 509-744-3040 | |
Neil Arthur Giddings, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 217 W Cataldo, Spokane, WA 99201 Phone: 509-624-2326 Fax: 509-744-3040 | |
Jason D. Roos, D.O. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 801 W 5th Ave, Suite 205, Spokane, WA 99204 Phone: 509-838-2531 Fax: 509-755-6580 | |
John Finley Hoffmann, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 217 W Cataldo, Spokane, WA 99201 Phone: 509-624-2326 Fax: 509-744-3040 | |
Alan T Pokorny, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 217 W Cataldo Ave Fl 2, Spokane, WA 99201 Phone: 509-624-2326 Fax: 509-744-3040 | |
Jordan Paul Sand, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 307 W 6th Ave Ste 200, Spokane, WA 99204 Phone: 509-324-2980 Fax: 094-189-4625 |